Clinical Trials
2 trialsNCT05219721 2025-06-11
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
Tongji Hospital
Phase 1 Recruiting
NCT05759793 2025-05-20
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
Nanjing IASO Biotechnology Co., Ltd.
Phase 1 Recruiting